Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
Autorzy:
Garciaz S; INSERM, CNRS, Department of Hematology, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Hospital MA; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Alary AS; Department of Molecular Biology, Institut Paoli-Calmettes, 13009 Marseille, France. Saillard C; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Hicheri Y; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Mohty B; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Rey J; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. D'Incan E; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Charbonnier A; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Villetard F; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Maisano V; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Lombardi L; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France. Ittel A; Department of Biopathology, Institut Paoli-Calmettes, 13009 Marseille, France. Mozziconacci MJ; Department of Biopathology, Institut Paoli-Calmettes, 13009 Marseille, France. Gelsi-BoyerV; Department of Biopathology, Institut Paoli-Calmettes, 13009 Marseille, France.; Predictive Laboratory Oncology, Equipe Labellisée Ligue Contre le Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR 1068, CNRS UMR725, Aix-Marseille Université, 13007 Marseille, France. Vey N; INSERM, CNRS, Department of Hematology, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.; Deparment of Hematology, Institut Paoli-Calmettes, 13009 Marseille, France.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Apr 16; Vol. 14 (8). Date of Electronic Publication: 2022 Apr 16.
Mutation patterns in essential thrombocythemia, polycythemia vera and secondary myelofibrosis.
Autorzy:
Wanquet A; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France.; b Aix-Marseille Université , Marseille , France.; c Département d'Hématologie , Institut Paoli-Calmettes , Marseille , France. Courtier F; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France.; b Aix-Marseille Université , Marseille , France. Guille A; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France. Carbuccia N; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France. Garnier S; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France. Adélaide J; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France. Gelsi-BoyerV; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France.; b Aix-Marseille Université , Marseille , France.; d Département de BioPathologie , Institut Paoli-Calmettes , Marseille , France. Mozziconacci MJ; d Département de BioPathologie , Institut Paoli-Calmettes , Marseille , France. Rey J; c Département d'Hématologie , Institut Paoli-Calmettes , Marseille , France. Vey N; b Aix-Marseille Université , Marseille , France.; c Département d'Hématologie , Institut Paoli-Calmettes , Marseille , France. Birnbaum D; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France.; b Aix-Marseille Université , Marseille , France. Murati A; a Laboratoire d'Oncologie Prédictive , Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille , Inserm U1068 CNRS UMR 7258 , Marseille , France.; b Aix-Marseille Université , Marseille , France.; d Département de BioPathologie , Institut Paoli-Calmettes , Marseille , France.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2019 May; Vol. 60 (5), pp. 1289-1293. Date of Electronic Publication: 2019 Jan 02.
Analysis and clinical characteristics of acute myeloid leukemia developing with prior or concurrent tumors in non cyto- or radiotherapy exposure patients in a single center.
59 Myelodysplastic syndromes with isolated neutropenia or thrombocytopenia: Are they refractory cytopenias with unilineage dysplasia? A GFM registry study
Clinical characteristics and prognosis analysis of patients with de novo ASXL1‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group.
A Novel Chalcone Derivative Regulates the Expression and Phosphorylation of ERK1/2 by Inhibiting Fli-1 Promoter Activity for Preventing the Malignant Progression of Erythroleukemia.
Increased copy number of imprinted genes in the chromosomal region 20q11-q13.32 is associated with resistance to antitumor agents in cancer cell lines.
Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution—a proof of principle study
The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.
High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.
Integrated genomic sequencing in myeloid blast crisis chronic myeloid leukemia (MBC-CML), identified potentially important findings in the context of leukemogenesis model.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies